找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardio-Oncology; Management of Toxici Antonio Russo,Nicola Maurea,Antonio Giordano Book 2022 The Editor(s) (if applicable) and The Author(s

[復(fù)制鏈接]
查看: 54419|回復(fù): 43
樓主
發(fā)表于 2025-3-21 16:41:49 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Cardio-Oncology
副標(biāo)題Management of Toxici
編輯Antonio Russo,Nicola Maurea,Antonio Giordano
視頻videohttp://file.papertrans.cn/222/221854/221854.mp4
概述Provides a complete and updated state-of-art review.Written by experts in the field.Addresses the future perspectives in the cardio-immunology field
叢書(shū)名稱(chēng)Current Clinical Pathology
圖書(shū)封面Titlebook: Cardio-Oncology; Management of Toxici Antonio Russo,Nicola Maurea,Antonio Giordano Book 2022 The Editor(s) (if applicable) and The Author(s
描述The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells. In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC).?This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies. The manuscript is divided into different sections starting from the relationship between cancer and immune system to let the reader understand the new molecular concepts under immunotherapy development. Subsequent chapters describe specifically the immunotherapy options in solid tumor treatment and the main features of the immuno-related cardiovascular complications. This volume is written by experts in the oncological and cardiovascular fields and aims to provide to clinicians who approach current cancer patients a useful tool to move through the paths of modern cardio-oncology. An important section would afford the most
出版日期Book 2022
關(guān)鍵詞Immunotherapy; cardiac toxicity; Physiopathology; Biomarkers; Immunology and cancer
版次1
doihttps://doi.org/10.1007/978-3-030-97744-3
isbn_softcover978-3-030-97746-7
isbn_ebook978-3-030-97744-3Series ISSN 2197-781X Series E-ISSN 2197-7828
issn_series 2197-781X
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱(chēng)Cardio-Oncology影響因子(影響力)




書(shū)目名稱(chēng)Cardio-Oncology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Cardio-Oncology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Cardio-Oncology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Cardio-Oncology被引頻次




書(shū)目名稱(chēng)Cardio-Oncology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Cardio-Oncology年度引用




書(shū)目名稱(chēng)Cardio-Oncology年度引用學(xué)科排名




書(shū)目名稱(chēng)Cardio-Oncology讀者反饋




書(shū)目名稱(chēng)Cardio-Oncology讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:05:26 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:20:21 | 只看該作者
地板
發(fā)表于 2025-3-22 07:29:30 | 只看該作者
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist,iological toxicities. Different types of cardiotoxicity can also occur with cell-based immune-therapy treatments (e.g., CAR-T), requiring specific diagnosis and management protocols. Because of the high morbidity and mortality, an early diagnosis of cardiological irAEs is essential for framing the o
5#
發(fā)表于 2025-3-22 12:44:09 | 只看該作者
6#
發(fā)表于 2025-3-22 16:27:13 | 只看該作者
7#
發(fā)表于 2025-3-22 18:36:25 | 只看該作者
8#
發(fā)表于 2025-3-22 23:07:32 | 只看該作者
9#
發(fā)表于 2025-3-23 05:06:39 | 只看該作者
Atemwegssicherung, Intubation und Beatmung,ligand-1 (PD-L1) checkpoint inhibitors have a crucial role in oncological treatments, resulting in an improvement of progression-free survival (PFS) and overall survival (OS) compared with standard treatments. Moreover, different safety analyses established that immunotherapy is well-tolerated with
10#
發(fā)表于 2025-3-23 06:12:27 | 只看該作者
,St?rungen der Vitalfunktionen,scular system. The most clinically relevant cardiovascular adverse event is myocarditis, with an incidence rate ranging from 0.27% of patients treated with single-agent ICIs up to 2.4% of patients treated with combinations. Immune-related myocarditis is burdened by high mortality, with a fatality ra
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 01:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
马尔康县| 临颍县| 铜山县| 呈贡县| 秦安县| 徐闻县| 凉城县| 阳高县| 县级市| 永善县| 南京市| 贵南县| 玉田县| 阿克陶县| 广汉市| 洛宁县| 宁乡县| 奉节县| 顺平县| 东宁县| 阳江市| 元谋县| 景洪市| 尤溪县| 汶川县| 承德市| 台南市| 江城| 中西区| 凤城市| 凤山市| 略阳县| 邹城市| 武强县| 武义县| 德清县| 呈贡县| 广东省| 岢岚县| 西平县| 镇远县|